Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

topical piperidine nitroxide MTS-01

A topical gel containing a cell permeable hydrophilic piperidine nitroxide with potential radioprotective and antioxidant activity. As a stable, free radical compound, MTS-01 may be able to protect cells against the damaging effects of reactive oxygen species (ROS), upon exposure to ionizing radiation and oxidative stress. The topically applied MTS-01 may protect normal tissue from radiation-induced toxicity, such as radiation dermatitis, during radiation therapy.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

US brand name:	Tempol
Code name:	MBM-02 MTS-01
Chemical structure:	1-piperidinyloxy, 4-hydroxy-2,2,6,6-tetramethyl- 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl

topical piperidine nitroxide MTS-01

Search NCI's Drug Dictionary